Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Share-based Compensation (2016 - 2026)

Healthequity has reported Share-based Compensation over the past 14 years, most recently at $19.1 million for Q1 2026.

  • Quarterly results put Share-based Compensation at $19.1 million for Q1 2026, down 11.94% from a year ago — trailing twelve months through Jan 2026 was $73.1 million (down 24.23% YoY), and the annual figure for FY2026 was $73.1 million, down 24.23%.
  • Share-based Compensation for Q1 2026 was $19.1 million at Healthequity, down from $20.5 million in the prior quarter.
  • Over the last five years, Share-based Compensation for HQY hit a ceiling of $32.0 million in Q2 2024 and a floor of $11.0 million in Q1 2022.
  • Median Share-based Compensation over the past 5 years was $19.1 million (2025), compared with a mean of $18.8 million.
  • Biggest five-year swings in Share-based Compensation: soared 75.9% in 2024 and later crashed 55.23% in 2025.
  • Healthequity's Share-based Compensation stood at $18.2 million in 2022, then increased by 19.22% to $21.7 million in 2023, then dropped by 2.49% to $21.1 million in 2024, then dropped by 2.75% to $20.5 million in 2025, then dropped by 6.94% to $19.1 million in 2026.
  • The last three reported values for Share-based Compensation were $19.1 million (Q1 2026), $20.5 million (Q4 2025), and $19.1 million (Q3 2025) per Business Quant data.